Share-based Payment Arrangement, Expense in USD of Ambrx Biopharma Cayman, Inc. from 2019 to Q2 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Ambrx Biopharma Cayman, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2019 to Q2 2023.
Ambrx Biopharma Cayman, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2023 was $2.89M, a 53.6% increase year-over-year.
Ambrx Biopharma Cayman, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.25M, a 47.3% decline from 2021.
Ambrx Biopharma Cayman, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.9M, a 874% increase from 2020.
Ambrx Biopharma Cayman, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $1.22M, a 33.5% decline from 2019.

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)

Share-based Payment Arrangement, Expense, Annual (USD)

Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2023	$2.89M	+$1.01M	+53.6%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-09
Q1 2023	$1.94M	+$288K	+17.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-11
Q2 2022	$1.88M			Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	$1.65M			Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$6.25M	-$5.6M	-47.3%	Jan 1, 2022	Dec 31, 2022	10-K	2023-03-30
2021	$11.9M	+$10.6M	+874%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-30
2020	$1.22M	-$614K	-33.5%	Jan 1, 2020	Dec 31, 2020	20-F	2022-04-26
2019	$1.83M			Jan 1, 2019	Dec 31, 2019	20-F	2022-04-26

* An asterisk sign (*) next to the value indicates that the value is likely invalid.